U.S. Markets closed

CTT Pharmaceutical Holdings, Inc. (CTTH)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0590+0.0089 (+17.76%)
At close: 3:51PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.0501
Open0.0510
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0461 - 0.0590
52 Week Range0.0301 - 0.2600
Volume154,250
Avg. Volume16,065
Market Cap18.974M
Beta (5Y Monthly)2.11
PE Ratio (TTM)N/A
EPS (TTM)-0.0800
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Government of Canada announces support for Rapid Housing in Hamilton
    CNW Group

    Government of Canada announces support for Rapid Housing in Hamilton

    HAMILTON, ON, Dec. 15, 2020 /CNW/ - Every Canadian deserves a safe and affordable place to call home.

  • CTT Enters into Business Development Partnership with 3 Rivers Biotech
    PR Newswire

    CTT Enters into Business Development Partnership with 3 Rivers Biotech

    CTT Pharmaceutical Holdings, Inc., (the "Company" or "CTT") (OTC: CTTH), an innovative life sciences company with a portfolio of IP in novel drug delivery systems, today announced that it has entered into a business development partnership with 3 Rivers Biotech, a pre-eminent tissue culture company. Under the agreement, 3 Rivers will leverage its network of suppliers to and manufacturers of Consumer Packaged Goods (CPG) to secure commercial partnerships based on CTT's patented sublingual wafer technology.

  • CTT Pharma Files Statement of Claim against Aurora Cannabis and Appoints Dr. Shane Morris to Advisory Board
    PR Newswire

    CTT Pharma Files Statement of Claim against Aurora Cannabis and Appoints Dr. Shane Morris to Advisory Board

    CTT Pharmaceutical Holdings, Inc., (OTC: CTTH), an innovative life sciences company with a portfolio of IP in novel drug delivery systems, today announced that its wholly owned Canadian subsidiary, CTT Pharma Inc. (the "Company" or "CTT"), has filed a statement of claim with the Ontario Superior Court of Justice against Aurora Cannabis. The Company is seeking compensation for Aurora's denial of contractual commitments with CTT, which includes expenses, royalties due, lost royalties and damages.